Sarepta Therapeutics Inc (SRPT) - Kapitalizatsiyaning foydaga nisbati

Sarepta Corp (SRPT) korporativ emblemasi va logotipi

Sarepta Therapeutics, Inc. (SRPT) gen terapiyalarini yetkazib berishda yuqori marjalarni ta'minlash uchun o'ta aniq kriologistikaga tayanadi. Kompaniyaning P/E baholashi biznesning haqiqiy qiymatini aniqlashga yordam beradi, bunda -13.60 ushbu parametrning qiymatini ko'rsatadi. Douglas Ingramning R&D ga yo'naltirilgan strategiyasi mushak distrofiyasi terapiyasi bo'yicha uning mavqeini mustahkamlaydi, orphan dori vositalariga bo'lgan talabning ortishi esa mijozlar bazasini kengaytirmoqda.

SRPT (Sarepta Corp) Narx-foyda koeffitsiyenti tarixi 04.07.2022dan 18.11.2026gacha

Sarepta Therapeutics, Inc. (SRPT) kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning umumiy tahlili:Sarepta, SRPT
Sarepta Corp asosiy tovari

P/E koeffitsiyenti biznesning bozor qiymatini uning sof foydasiga nisbatan belgilaydi, bu esa investorga daromadning har bir dollari uchun to'langan premiumni baholash imkonini beradi. Joriy P/E baholash darajasini tahlil qilish orqali, Sarepta Therapeutics, Inc. (SRPT) aksiyalarining premiumini gen terapiyasi yetakchisi sifatidagi favqulodda mavqei bilan bog'lash mumkin, bunda patent ustunliklari va RNA dori sintezining murakkabligi generik dori vositalari tomonidan raqobat xatarlarini minimallashtiradi.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|TWST (twistbioscience.com) - P/E multiplikatori|10x Genomics, Inc. (TXG) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NTLA (Intellia Therapeutics, Inc.)|STOK - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati biolifesolutions.com BLFS|Biznesning o‘zini qoplash muddati Wave Life Sciences Corp (WVE)|MAZE - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati SION (Sionna Therapeutics Inc)|PRME: P/E multiplikatori|Taysha - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati uniQure NV|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati